Wu, Di https://orcid.org/0000-0001-9748-4408
Yan, Renhong https://orcid.org/0000-0002-7122-6547
Song, Siyuan https://orcid.org/0009-0005-8278-3954
Swansiger, Andrew K. https://orcid.org/0000-0002-7320-5491
Li, Yaning
Prell, James S. https://orcid.org/0000-0002-7505-9168
Zhou, Qiang https://orcid.org/0000-0002-6237-8813
Robinson, Carol V. https://orcid.org/0000-0001-7829-5505
Funding for this research was provided by:
Wellcome Trust (221795/Z/20/Z)
National Natural Science Foundation of China (82202517)
National Science Foundation (CHE-1752994)
Article History
Received: 5 September 2023
Accepted: 17 April 2024
First Online: 2 May 2024
Competing interests
: C.V.R. is a cofounder of and consultant at OMass Therapeutics. The remaining authors declare no competing interests.